ADVFN Logo
Registration Strip Icon for charts 실시간 차트, 분석 도구 및 가격을 받으려면 등록하세요.

REGN Regeneron Pharmaceuticals Inc

981.20
16.31 (1.69%)
24 2월(2) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Regeneron Pharmaceuticals Inc REGN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
16.31 1.69% 981.20 10:00:00
개장가 저가 고가 종가 전일 종가
975.00 969.15 985.64 981.20 964.89
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
24/02/202406:04EDGAR2Form 144 - Report of proposed sale of securities
23/02/202415:00GLOBEDupixent® (dupilumab) sBLA Accepted for FDA Priority Review..
23/02/202407:10EDGAR2Form 144 - Report of proposed sale of securities
23/02/202406:06EDGAR2Form 144 - Report of proposed sale of securities
21/02/202421:00GLOBELinvoseltamab BLA for Treatment of Relapsed/Refractory..
21/02/202406:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/02/202406:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/02/202414:59GLOBEJapan First in the World to Approve Dupixent® (dupilumab)..
15/02/202407:08EDGAR2Form 144 - Report of proposed sale of securities
13/02/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/02/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202408:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
10/02/202406:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/02/202406:04EDGAR2Form 144 - Report of proposed sale of securities
10/02/202402:22EDGAR2Form 144 - Report of proposed sale of securities
09/02/202406:56EDGAR2Form 144 - Report of proposed sale of securities
09/02/202406:26EDGAR2Form 144 - Report of proposed sale of securities
09/02/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/02/202406:01EDGAR2Form 3 - Initial statement of beneficial ownership of..
08/02/202407:59EDGAR2Form 144 - Report of proposed sale of securities
08/02/202407:07EDGAR2Form 144 - Report of proposed sale of securities
08/02/202406:35EDGAR2Form 144 - Report of proposed sale of securities
07/02/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/02/202406:05GLOBERegeneron Announces Investor Conference Presentations
06/02/202407:06EDGAR2Form 144 - Report of proposed sale of securities
06/02/202406:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/02/202423:16EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
03/02/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/02/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/02/202421:16EDGAR2Form 8-K - Current report
02/02/202420:30GLOBERegeneron Reports Fourth Quarter and Full Year 2023..
02/02/202420:00GLOBELinvoseltamab Receives EMA Filing Acceptance for Treatment..
02/02/202406:47EDGAR2Form 144 - Report of proposed sale of securities
02/02/202406:10EDGAR2Form 144 - Report of proposed sale of securities
01/02/202406:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
01/02/202406:17EDGAR2Form 8-K - Current report
31/01/202407:02EDGAR2Form 144 - Report of proposed sale of securities
30/01/202423:25APSBiotech Shares Soar Premarket On Sale Of R&D Assets
30/01/202421:00GLOBERegeneron Announces Formation of Regeneron Cell Medicines..
26/01/202406:59EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
26/01/202406:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202406:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/01/202404:29GLOBEDupixent® (dupilumab) FDA Approved as First and Only..
25/01/202402:05PRNUSTop 40 High School Scientists in Prestigious Regeneron..
25/01/202402:00GLOBETop 40 High School Scientists in Prestigious Regeneron..
24/01/202406:17EDGAR2Form 144 - Report of proposed sale of securities
19/01/202406:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..

최근 히스토리

Delayed Upgrade Clock

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관

도움 및 지원받기: kr-support@advfn.com